China has become a “core contributor” and “emerging pillar force” of the global biomedical industry, firmly ranking among the top of the world’s second echelon. Zhangjiang Pharma Valley is one of the regions in China with the most complete biomedical industry chain, the most concentrated talent pool, the most active innovation atmosphere, the most efficient R&D capability and the optimal industrial ecology.

The team of Pudong Life Science Company, the operation and management entity of Zhangjiang Pharma Valley, will visit the Boston area on June 21, and plans to organize a symposium for local biomedical innovation enterprises. We will introduce the industrial ecosystem, policy advantages and full-chain business environment of Zhangjiang Pharma Valley, communicate with innovative enterprises in Boston, understand their intentions and main needs for developing business in China, and explore the possibility of future cooperation.

I. Conference Time

15:00-20:00, Sunday, June 21, 2026

II. Conference Venue

Medicilon Boston Site (20 Maguire Road, Suite 103, Lexington, MA 02421)

III. Conference Objectives

Promote industrial advantages‌: Introduce the industrial development foundation, full-chain innovation ecosystem, special support policies and first-class business environment of Zhangjiang Pharma Valley to biomedical innovation enterprises in Boston.

Connect with corporate demands‌: Investigate the layout intentions and core demands of Boston biomedical innovation enterprises to develop in China, and listen to enterprises’ specific suggestions on the development environment and industrial policies of the Chinese market.

Explore diverse cooperation possibilities‌: Build a communication bridge between China’s industrial undertaking platform and the source of North American innovation, tap cooperation opportunities in cutting-edge technology, clinical resources, achievement transformation, capital linkage and other fields, and achieve two-way empowerment and mutual benefit.

IV. Organizers

Shanghai Pudong Life Science Industry Development Co., Ltd.

Medicilon

V. Member of delegation from Zhangjiang

• Ms. Lou Qi, Vice General Manager of Zhangjiang Group
• Ms. Wang Cong, Deputy General Manager of Pudong Life Sciences
• Ms. Cao Li, Assistant to the General Manager of Pudong Life Sciences Company
• Ms. Jin Yuting, Manager of Medical Devices Department, Pudong Life Sciences Company
• Mr. Yu Jiachen, Director of the General Office of Pudong Life Sciences Company

VI.Conference Agenda